Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Peering Into Intellia Therapeutics's Recent Short Interest
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
JP Morgan Maintains Overweight on Vertex Pharmaceuticals, Lowers Price Target to $500
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?